Tunable Lipid Coatings Enable Cytoplasmic siRNA Delivery by DNA Origami
Source abstract
Abstract
DNA origami nanostructures (DONs) offer precise architectural control for small RNA delivery, but their performance is limited by their susceptibility to nuclease degradation, weak cellular uptake, and inefficient endosomal escape. Here, we introduce an electrostatic lipid-coating strategy that introduces membrane-like properties to DONs while maintaining their structural integrity. By coincubating folded DONs with liposomes composed of a defined mixture of zwitterionic and cationic lipids, we identify a formulation window that yields colloidally stable, monodisperse lipid-coated DONs (LCDs). Systematic variation of the zwitterionic-to-cationic lipid ratio revealed that the fraction of cationic lipids strongly regulates the rate and extent of cellular uptake, with the 50 mol % cationic lipid content emerging as the most effective formulation. LCDs exhibited faster and more extensive cellular internalization and reduced early endosomal retention compared with PEG-coated DONs. The 50 mol % cationic formulation enabled efficient siRNA silencing comparable to benchmark lipid nanoparticles, underscoring the importance of rapid uptake and early endosomal escape for functional delivery while maintaining high cell viability. These findings establish an approach for integrating lipid functionalities onto DONs to improve cytoplasmic delivery while preserving full design flexibility.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Advanced Drug Delivery and Biomaterials, Louvain Drug Research Institute
UCLouvain
Programmable Biomaterials Laboratory, Institute of Materials, Interfaculty Bioengineering Institute, School of Engineering
Ecole Polytechnique Fédérale Lausanne
Funding
HORIZON EUROPE European Research Council · Fonds De La Recherche Scientifique - FNRS
References (55)
Show source-provided references
1. 10.1073/pnas.230780012010.1073/pnas.2307800120 ↗
2. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
3. Dey S. · Nat. Rev. Methods Primers · 2021 · 1 · 1310.1038/s43586-020-00009-8 ↗
4. 10.1038/nature0458610.1038/nature04586 ↗
5. 10.1021/acsnano.3c0655210.1021/acsnano.3c06552 ↗
6. 10.1021/acs.nanolett.5c0478210.1021/acs.nanolett.5c04782 ↗
7. 10.1016/j.nano.2023.10272210.1016/j.nano.2023.102722 ↗
8. 10.1002/anie.20200984210.1002/anie.202009842 ↗
9. 10.1093/nar/gkac04910.1093/nar/gkac049 ↗
10. 10.1021/nl500677j10.1021/nl500677j ↗
11. 10.1021/nn501191410.1021/nn5011914 ↗
12. 10.1002/smll.20230193510.1002/smll.202301935 ↗
13. 10.1038/ncomms1565410.1038/ncomms15654 ↗
14. 10.1021/acspolymersau.4c0008510.1021/acspolymersau.4c00085 ↗
15. 10.1021/nl302638g10.1021/nl302638g ↗
16. 10.1021/acs.biomac.2c0028210.1021/acs.biomac.2c00282 ↗
17. 10.1016/j.asems.2024.10009810.1016/j.asems.2024.100098 ↗
18. 10.1039/C5NR08355A10.1039/C5NR08355A ↗
19. 10.1039/C7NR09461B10.1039/C7NR09461B ↗
20. 10.1002/adma.20221202410.1002/adma.202212024 ↗
21. 10.1021/acs.chemmater.0c0211110.1021/acs.chemmater.0c02111 ↗
22. Perrault, S. D.; Shih, W. M. 3D DNA Nanostructure: methods and Protocols ; Eds. Ke, Y.; Wang, P. Springer: New York, NY, 2017 pp. 165–184.10.1007/978-1-4939-6454-3_12 ↗
23. 10.1038/s41467-018-02905-w10.1038/s41467-018-02905-w ↗
24. 10.1039/D3CC04677J.10.1039/D3CC04677J. ↗
25. 10.1039/D2NR05749B10.1039/D2NR05749B ↗
26. 10.1007/s40259-022-00549-310.1007/s40259-022-00549-3 ↗
27. 10.3390/ph1310029410.3390/ph13100294 ↗
28. 10.3390/vaccines1210114810.3390/vaccines12101148 ↗
29. 10.1016/j.jconrel.2021.12.02710.1016/j.jconrel.2021.12.027 ↗
30. 10.1038/s41573-023-00859-310.1038/s41573-023-00859-3 ↗
31. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
32. 10.1038/s41467-021-27493-010.1038/s41467-021-27493-0 ↗
33. 10.1021/acsnano.4c0234110.1021/acsnano.4c02341 ↗
34. 10.1002/mco2.7041410.1002/mco2.70414 ↗
35. 10.1021/acsnano.1c0554010.1021/acsnano.1c05540 ↗
36. 10.1021/acs.biomac.4c0019210.1021/acs.biomac.4c00192 ↗
37. 10.1093/nar/gkn100310.1093/nar/gkn1003 ↗
38. 10.1103/PhysRevX.14.03104210.1103/PhysRevX.14.031042 ↗
39. 10.1021/acsnano.9b0565010.1021/acsnano.9b05650 ↗
40. 10.1021/acspolymersau.5c0001210.1021/acspolymersau.5c00012 ↗
41. 10.1038/s41467-024-45666-510.1038/s41467-024-45666-5 ↗
42. 10.1038/s41563-020-00886-010.1038/s41563-020-00886-0 ↗
43. 10.1021/acs.accounts.6b0043510.1021/acs.accounts.6b00435 ↗
44. 10.1038/s41427-021-00320-010.1038/s41427-021-00320-0 ↗
45. 10.1038/s41467-019-12906-y10.1038/s41467-019-12906-y ↗
46. 10.1021/acsomega.3c0913110.1021/acsomega.3c09131 ↗
47. 10.1038/s41467-022-28776-w10.1038/s41467-022-28776-w ↗
48. 10.1021/acs.accounts.9b0017710.1021/acs.accounts.9b00177 ↗
49. 10.1021/acs.jpclett.1c0257210.1021/acs.jpclett.1c02572 ↗
50. 10.1002/adhm.20230031910.1002/adhm.202300319 ↗
51. 10.1038/s41427-022-00453-w10.1038/s41427-022-00453-w ↗
52. 10.1093/jn/134.3.48910.1093/jn/134.3.489 ↗
53. 10.3390/jfb502004310.3390/jfb5020043 ↗
54. 10.1002/smtd.20240104110.1002/smtd.202401041 ↗
55. 10.1016/j.biomaterials.2025.12358910.1016/j.biomaterials.2025.123589 ↗